GE HealthCare Technologies Leadership Change
Taha Kass-Hout notified GE HealthCare Technologies Inc. of his resignation as Chief Science and Technology Officer on November 4, 2026. His departure is effective December 31, 2026.
ALFA USA Filings
Every alert, straight from SEC EDGAR
Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All GE HealthCare Technologies Inc. filings on SEC EDGAR ↗
Filing type
Alerts
Time
4 alerts
Taha Kass-Hout notified GE HealthCare Technologies Inc. of his resignation as Chief Science and Technology Officer on November 4, 2026. His departure is effective December 31, 2026.
For the three months ended September 30, 2026, GE HealthCare reported total revenues of $5.5 billion, a 7% increase compared to the prior year, and net income attributable to the company of $615 million. The company's nine-month performance showed steady growth with net income reaching $1.56 billion, while the balance sheet reflected a significant increase in goodwill to $15.1 billion following acquisition activities.
GE HealthCare reported third quarter 2026 financial results with revenue growth of 7.2% to $5.5 billion and raised its full-year guidance. The company also announced that Jeannette Bankes will resign as President and CEO of Patient Care Solutions, to be succeeded by Neal Sandy on November 16, 2026.
“We delivered strong top-line growth and margin expansion across all segments, and robust EPS growth in the third quarter. This reflects our teams’ commercial execution, disciplined operational focus enabled by Heartbeat, and continued customer adoption of our innovations. With our improved performance year-to-date and momentum in the business, we are raising guidance for the year.”
Peter Arduini, GE HealthCare President and CEO
GE HealthCare Technologies Inc. has appointed Pascal Desroches, the current CFO of AT&T, to its Board of Directors effective January 4, 2027. Mr. Desroches will also serve on the Audit and Talent, Culture, and Compensation Committees, bringing over 30 years of experience in finance and corporate strategy to the board.